Rapt Therapeutics Inc (NASDAQ:RAPT)

BATS BZX Real-Time Price
As of 3:45pm ET
 +0.465 / +1.92%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Rapt Therapeutics Inc have a median target of 50.50, with a high estimate of 61.00 and a low estimate of 30.00. The median estimate represents a +104.70% increase from the last price of 24.67.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Rapt Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Dec 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.22%
Growthannually -7.37%


Growthquarterly -62.01%
Growthannually -45.48%
Key to the earnings and sales forecast charts.